2018 Round Table

Biodrugs

2018 bio drugs

The need for regulations or specifications concerning the registration of biosimilars

Evaluate biosimilars already on the market and associate the social security throughout the process of evaluation and registration of biomedicines

Put in place an adequate structure for the control
- What tools are needed : Evaluation, Registration, Dossier

Audience

Attending Experts

Pr. Ruth Lopert

Michael Muenzenberg

Wilkeir Ribeiro Filho

Dr. Valderilio Azevedo

EDUMED

Contact us

Logo_Algéria-removebg-preview
LOGO_PWF_SIGNATURE-removebg-preview

Tour Sebastopol, 3 Quai Kleber, 67000 Strasbourg

+33 - 388 - 23 - 70 - 92
+33 - 643 - 12 - 95 -13
+213 - 549 - 55 - 62 - 05

en_US